- 全部删除
- 您的购物车当前为空
Fontolizumab (HuZAF) 是一种人源化的lgG1单克隆抗IFN-gamma(IFN-γ)抗体,耐受良好且免疫原性小,在临床中通过静脉注射给药,可用于克罗恩病的研究。
为众多的药物研发团队赋能,
让新药发现更简单!
Fontolizumab (HuZAF) 是一种人源化的lgG1单克隆抗IFN-gamma(IFN-γ)抗体,耐受良好且免疫原性小,在临床中通过静脉注射给药,可用于克罗恩病的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,230 | In stock | |
5 mg | ¥ 5,600 | In stock | |
10 mg | ¥ 7,890 | In stock | |
25 mg | ¥ 11,700 | In stock | |
50 mg | ¥ 15,800 | In stock |
Fontolizumab 相关产品
产品描述 | Fontolizumab (HuZAF) is a humanised IgG1 monoclonal anti-IFN-gamma (IFN-γ) antibody with good tolerability and low immunogenicity. It is administered intravenously in clinical settings and can be used for the study of Crohn's disease. |
别名 | 芳妥珠单抗, HuZAF, Anti-Human IFNG Recombinant Antibody |
分子量 | 150 (kDa) |
CAS No. | 326859-36-3 |
颜色 | Transparent |
物理性状 | Liquid |
存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容